AI assistant
Pfizer Ltd. — Regulatory Filings 2024
Mar 19, 2024
60507_rns_2024-03-19_a6337387-3d03-446c-9df8-e417746d0fef.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [100 x 41] intentionally omitted <==
Pfizer Limited
The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274
March 19, 2024
The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER
Dear Sirs,
Sub: Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure – Requirements) Regulations, 2015 Resignation of Cost Auditor.
Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that M/s. RA & Co., Cost Accountants (Firm Registration No. 000242) have vide their letter dated March 18, 2024 (copy attached) have tendered their resignation on account of ineligibility to continue as Cost Auditors of the Company for the financial year ending March 31, 2024, consequent to inheritance of Company’s shares by Mr. Rasesh Chokshi, one of the Partners of the firm.
Further, the information required in terms of Regulation 30 read with Schedule Ill - Para A (7) of Part A of the SEBI Listing Regulations and SEBI Master Circular bearing Ref. No. SEBI/HO/CFD/ CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 is enclosed as ‘Annexure-I’ to this letter.
Please take the above on record.
Thanking you,
Yours truly,
For Pfizer Limited
PRAJEET Digitally signed by PRAJEET NAIR NAIR Date: 2024.03.19 14:52:47 +05'30' Prajeet Nair
Director – Corporate Services & Company Secretary
CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerltd.co.in
ANNEXURE – I
Information as required under Regulation 30 - Part A of Para A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
| Sr.no. | Particulars | Details |
|---|---|---|
| 1. | Reasons for change | Resignation as Cost Auditor of the Company for the Financial Year ending March 31, 2024. |
| 2. | Date of Cessation | March 18, 2024 |
| 3. | Reasons for resignation | M/s. RA & Co., Cost Accountants have expressed their ineligibility to continue as Cost Auditors of the Company for the financial year ending March 31, 2024, consequent to inheritance of Company’s shares by Mr. Rasesh Chokshi, one of the Partners of the firm. |
| 4. | Brief profile (in case of appointment) |
Not Applicable |
| 5. | Disclosure of relationships between directors (in case of appointment of a director) |
Not Applicable |
==> picture [483 x 72] intentionally omitted <==
��������[��] ������������
���
The Board of Directors,
Pfizer Limited
���������������������[��] �������� �������������������������������������������������� ��������������������������������
���������������
���������������������������������������������������������[��] ������������
��������������������������������������������������������������������������������������
�������������������������������������������������������������������������
���������������������������������������������������������������������������������������������������������� ���������������������������������������������
�������������������������������������������������������������������������������������������������������� ����������
����������������������������������������������������������������������������
��������������
������������������
��������������
����������������������������������
Digitally signed by RASESH VIPIN RASESH VIPIN CHOKSHI CHOKSHI Date: 2024.03.18 15:02:45 +05'30'
�����������������
������������
�������������������
==> picture [531 x 55] intentionally omitted <==